Ethnic and gender differences in the management of type 2 diabetes: a cross-sectional study from Norwegian general practice by Tran, Anh Thi et al.
RESEARCH ARTICLE Open Access
Ethnic and gender differences in the
management of type 2 diabetes: a cross-
sectional study from Norwegian general
practice
Anh Thi Tran1* , Tore Julsrud Berg2,3, Bjørn Gjelsvik1, Ibrahimu Mdala1, Geir Thue4,5, John Graham Cooper4,6,
Kjersti Nøkleby1, Tor Claudi7, Åsne Bakke5,6, Sverre Sandberg4,5,8 and Anne Karen Jenum1,9
Abstract
Background: Ethnic minority groups from Asia and Africa living in Western countries have a higher prevalence of
type 2 diabetes (T2DM) than the general population. We aimed to assess ethnic differences in diabetes care by
gender.
Methods: Population-based, cross-sectional study identified 10,161 individuals with T2DM cared for by 282 General
Practitioners (GP) in Norway. Ethnicity was based on country of birth. Multilevel regression models adjusted for
individual and GP factors were applied to evaluate ethnic differences by gender.
Results: Diabetes was diagnosed at a younger mean age in all other ethnic groups compared with Westerners
(men: 45.9–51.6 years vs. 56.4 years, women: 44.9–53.8 years vs. 59.1 years). Among Westerners mean age at
diagnosis was 2.7 years higher in women compared with men, while no gender difference in age at diagnosis was
found in any minority group. Daily smoking was most common among Eastern European, South Asian and Middle
East/North African men. In both genders, we found no ethnic differences in processes of care (GPs’ measurement of
HbA1c, blood pressure, LDL-cholesterol, creatinine). The proportion who achieved the HbA1c treatment target was
higher in Westerners (men: 62.3%; women: 66.1%), than in ethnic minorities (men 48.2%; women 53.5%). Compared
with Western men, the odds ratio (OR) for achieving the target was 0.45 (95% CI 0.27 to 0.73) in Eastern European;
0.67 (0.51 to 0.87) in South Asian and 0.62 (0.43 to 0.88) in Middle Eastern/North African men. Compared with
Western women, OR was 0.49 (0.28 to 0.87) in Eastern European and 0.64 (0.47 to 0.86) South Asian women.
Compared with Westerners, the blood pressure target was more often achieved in South Asians and Middle
Easterners/North Africans in both genders. Small ethnic differences in achieving the LDL-cholesterol treatment
target by gender were found.
Conclusion: Diabetes was diagnosed at a considerably earlier age in both minority men and minority women
compared with Westerners. Several minority groups had worse glycaemic control compared with Westerners in
both genders, which implies that it is necessary to improve glucose lowering treatment for the minority groups.
Smoking cessation advice should particularly be offered to men in most minority groups.
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Background
Ethnic groups originating from Asia and Africa living in
Western countries have a higher prevalence of type 2
diabetes (T2DM) than the general population [1] and
develop T2DM at a younger age [2–4], increasing the
risk of achieving complications relatively early in life [5].
The care of individuals with T2DM and the outcomes
are affected by a complex mix of individual factors such
as ethnicity, gender, language skills, socioeconomic pos-
ition, adherence to treatment, health care provider and
health care system factors [6, 7]. Ethnic disparities in the
care of T2DM have been reported from several countries
[4, 8–14]. A large observational study from the Swedish
National Diabetes Register showed that minorities of
non-Western origin had poorer glycaemic control and a
higher risk of developing albuminuria, despite early use
of glucose-lowering agents [11]. Another observational
study from The Scottish Care Information Diabetes re-
vealed that people with diabetes with Pakistani origin
had an increased risk of cardiovascular disease (CVD),
whereas those of Chinese origin had a lower risk com-
pared with Caucasians [4]. Similarly, minorities from
Asia and the Caribbean living in the UK were less likely
to achieve treatment targets for HbA1c, blood pressure
(BP) and total cholesterol compared with Caucasians,
even after the introduction of financial incentives to im-
prove care [15]. In our study from 2005, we found that
the age at the time of diagnosis was 8–15 years younger
in Eastern Asians, South Asians and Middle Easterners/
North Africans compared with Norwegians [2]. All mi-
nority groups had higher mean HbA1c compared with
Norwegians [2]. Current diabetes guidelines emphasise
that treatment and care should take into account indi-
vidual needs and preferences [6, 16].
Few studies address ethnic differences in the age at the
time of diagnosis and in the management of T2DM by
gender [3]. In the present study, we aimed to investigate
whether there were ethnic differences in age when dia-
betes was diagnosed, clinical risk factors, processes of
care, prescribed medication and achievement of treat-
ment targets in primary care in Norway. In addition, we
analyzed the effect of gender in the different ethnic
groups.
Methods
Design and setting of the study
We used data from a large population-based, cross-
sectional survey, the ROSA 4 study, assessing the quality
of diabetes care in general practice in Norway in 2014
[17]. In total, 106 practices with 367 general practi-
tioners (GPs) in three of four health regions in Norway
were invited. Of the invited practices, 77 practices with
282 GPs participated the study. Detailed information
about the methods is described elsewhere [7, 17]. The
ROSA 4 study was approved by the Regional Ethical
Committee.
Participants
In total, 11,428 individuals with a diabetes diagnosis were
identified from electronic health records (EHRs). We ex-
cluded individuals with other diabetes types than T2DM
(n = 1183), those from regions with less than 40 individ-
uals (Central and South America, South of Sahara Africa,
and Oceania) (n = 72), and those with unknown country
of birth (n = 12), leaving 10,161 individuals with T2DM to
be included in the study (See Additional file 1: Figure S1).
Data collection
Data were collected from January 2015 to April 2016. A
software program was used to identify all individuals
≥18 years with a diabetes diagnosis in 2012–2014, and to
capture pre-defined data such as results of the blood
tests, urine tests and prescriptions of medications from
the included GPs’ EHRs. Research nurses examined the
EHRs to verify the diabetes diagnosis. In addition they
collected clinically relevant data not captured by the
electronic software such as year of diagnosis, screening
procedures and complications [7, 17].
Variables
We extracted information from the EHRs about individ-
ual level characteristics (age, gender, diabetes duration);
processes of care (recorded measurements of HbA1c,
BP, LDL-cholesterol, creatinine, albuminuria, body
height, body weight, eye examination, foot examination
(foot pulse and/or sensation) and smoking habits; medi-
cation use (prescriptions of glucose lowering-, antihyper-
tensive- and lipid lowering- agents) and level of HbA1c,
BP and LDL-cholesterol. Further, information about cor-
onary heart diseases (CHD) (i.e. angina, myocardial in-
farction, percutaneous coronary intervention/coronary
artery bypass surgery) was extracted and coded as “yes”
or “no”. For the majority of variables, the most recently
recorded value from October 1st 2013 to December 31st
2014 was used, for eye examination July 1st 2012 to De-
cember 31st 2014, and for body height and smoking habits
if ever registered. Treatment targets were based on key
recommendations in the Norwegian 2009-guildelines:
HbA1c ≤53mmol/mol (7.0%); the intervention threshold
for BP was > 140/85mmHg with treatment target ≤135/
80mmHg while the intervention threshold for LDL-
cholesterol was > 3.5mmol/L with treatment target ≤1.8
mmol/L or 2.5 mmol/L for individuals with or without
known coronary heart diseases (CHD) respectively.
In order to investigate ethnic differences in the man-
agement of diabetes care, we linked information about
country of birth, educational level and number of years
resident in Norway, obtained from “Statistics Norway” to
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the EHR data. Ethnicity was based on country of birth
and classified as shown in, Additional file 1: Figure S1)
Westerners, 2) Eastern Europeans, 3) Eastern Asians, 4)
South Asians, 5) Middle Easterners and North Africans
(MENA) and 6) Eastern Africans. Education was cate-
gorised as: 1) pre-primary and primary education, 2) sec-
ondary education and 3) tertiary education [18].
A questionnaire sent to participating practices pro-
vided self-reported information about GP characteristics
such as age, gender, specialist status and number of
years working as GP in Norway.
Statistical analyses
We performed analyses stratified by ethnicity and com-
pared differences in clinical characteristics, processes of
care, medication use and achievement of treatment targets
between ethnic groups, and for all minority groups merged,
with Westerners as reference. Further, we performed cor-
responding ethnic comparisons stratified by gender. De-
scriptive statistics in the form of frequencies (proportions)
and means were used. The Chi-square tests were used to
compare ethnic differences in proportions of categorical
variables while One-Way ANOVA tests with post hoc tests
were used to compare ethnic differences in means of con-
tinuous variables with Westerners as reference.
Multilevel regression models were used to account for
individuals’ data that were nested within practices.
Multilevel binary logistic regression models were fitted
to the data on proportions while multilevel linear regres-
sion models were fitted to intermediate continuous out-
comes. All models were adjusted for individual level
characteristics (age, gender, diabetes duration and edu-
cation), GP level characteristics (gender, specialist status
and years working as GP in Norway) and county of resi-
dence. We also considered two-way interactions of eth-
nicity and gender with the outcome measures. However,
with the exception of regression models for body height,
body weight and smoking habits, the inclusion of these
interaction terms did not give better models, hence we
did not include the interaction terms. There were no dif-
ferences in missing data for HbA1c, blood pressure and
LDL-cholesterol across ethnicities and gender. There-
fore, we included cases with complete data in the regres-
sion analyses for mean HbA1c, BP and LDL-cholesterol
and achievement of treatment targets. Due to large dif-
ferences in the mean ages between the Westerners and
the other ethnic groups, we also performed a sensitivity
analysis for achievement of HbA1c target after having
excluded Westerners ≥76 years. When comparing esti-
mates from the minority groups and the reference
group, the difference was considered to be significant
if the 95% confidence intervals did not overlap. The




Of the 10,161 individuals with T2DM, 84% were
classified as Westerners and 16% as ethnic minor-
ities, with South Asians and Middle Easterners/North
Africans as the largest groups. Among the 8492
Westerners, 269 (3.2%) were born outside Norway.
All minority groups had significantly lower mean age
at the time of diagnosis compared with Westerners
(46.4–52.6 years vs. 57.6 years) (Table 1). Among
Westerners, the age at diagnosis was lower in men
than in women (56.4 years vs. 59.1 years), but no dif-
ferences in age at diagnosis between men and
women were found in the minority groups (Fig. 1).
Ethnic differences in BMI were observed, and
women of East Asians had the lowest, while Middle
Easterners/North Africans had the highest BMI
(Table 1). About 35% of men from Middle East/
North Africa and Eastern Europe were daily smokers,
compared with 22% in their Western counterparts.
Among women, the highest prevalence of daily
smokers was found in Eastern Europeans, while very
few South Asian and Eastern African women were
daily smokers (Table 1).
Processes of care
Ethnicity had little effect on the GPs performance of
the majority of the processes of care after adjustments
(Additional file 2: Table S1). Body height and body
weight were less often recorded in men in several minority
groups, whereas smoking habits were recorded less often
in women in most minority groups compared with their
Western counterparts. Performance of albuminuria and
foot examinations were low in all groups in both genders
(Table 2).
Medication use
The proportion of minority groups who received pre-
scriptions for glucose-lowering agents and who re-
ceived three or more glucose-lowering agents was
significantly higher than in Westerners (Table 3).
However, the proportion of minority groups who re-
ceived prescriptions for anti-hypertensive was signifi-
cantly lower than in Westerners. Only Eastern
Africans received prescriptions for lipid-lowering
agents less frequently than Westerners. When strati-
fied by gender, similar ethnic differences in prescrip-
tions were found (Additional file 3: Table S2).
HbA1c, systolic blood pressure and LDL cholesterol
All minority groups except Eastern Africans had
higher mean HbA1c levels, and most minority groups
had lower mean systolic BP (SBP) levels and diastolic
BP (DBP) levels than Westerners, while no ethnic
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differences were found for mean LDL-cholesterol
(Table 4). Most ethnic differences in HbA1c and
blood pressure were also present for both genders
(Additional file 4: Table S3).
Achievement of treatment targets
The treatment targets were achieved in the following
proportions of Westerners: HbA1c 64.0%, blood pres-
sure 48.1% and LDL-cholesterol 48.6%. Compared with
Westerners, three minority groups achieved the HbA1c
target less often (Eastern Europeans: OR 0.47 (0.33 to
0.69); South Asians: OR 0.65 (0.53 to 0.79); Middle East-
erners/North Africans: OR 0.64 (0.48 to 0.84). Similarly,
three minority groups achieved the blood pressure target
more often than Westerners (South Asians: OR 1.91
(1.56 to 2.35), Middle Easterners/North Africans: OR
1.56 (1.17 to 2.07); Eastern Africans: OR 1.78 (1.09 to
2.89). Only Eastern Africans were more likely to achieve
the LDL-cholesterol target compared with Westerners
Fig. 1 Age at diagnosis by ethnicity and gender. Mean age and 95%
CI. The One-Way ANOVA tests with post hoc tests were applied to
compare ethnic differences with Westerners as reference. * No
overlap in 95% CIs, indicating significant difference between
Westerners and the particular minority group
Table 2 Percentage of individuals with type 2 diabetes receiving specific processes of care by ethnicity and gender
Features recorded in
electronic health
records % (95% CI)
Ethnicity
Westerners Eastern Europeans Eastern Asians South Asians MENA a Eastern Africans
Men, n 4698 103 76 430 200 80
HbA1c 89.2 (87.4 to 91.0) 86.5 (78.8 to 94.2) 88.8 (81.5 to 96.1) 92.8 (89.9 to 95.7) 89.2 (84.4 to 94.0) 89.2 (82.1 to 96.4)
Blood pressure 89.0 (87.4 to 90.6) 82.3 (73.9 to 90.8) 90.2 (83.4 to 96.9) 91.6 (88.5 to 94.7) 87.6 (82.8 to 92.6) 84.3 (75.9 to 92.7)
LDL-cholesterol 68.7 (64.7 to 72.8) 71.6 (60.8 to 82.4) 72.8 (60.9 to 84.7) 73.1 (66.7 to 79.4) 73.7 (65.9 to 81.6) 66.4 (53.6 to 79.2)
Creatinine/ e-GFR 82.13 (80.6 to 85.6) 80.0 (71.0 to 89.0) 82.9 (74.4 to 91.8) 84.3 (79.8 to 88.9) 83.7 (78.0 to 89.5) 84.9 (76.9 to 93.0)
Albuminuria 23.4 (17.0 to 29.9) 25.0 (13.5 to 36.5) 25.4 (13.2 to 37.7) 17.6 (11.1 to 24.2) 22.4 (13.5 to 31.2) 25.0 (12.5 to 37.5)
Body height 75.8 (71.1 to 80.6) 64.8 (52.9 to 76.8) 67.8 (55.2 to 80.5) 62.3 (43.0 to 70.3)* 59.5 (48.8 to 68.3)* 51.9 (37.9 to 66.0)*
Body weight 58.1 (52.5 to 63.7) 42.7 (30.3 to 55.2) 48.1 (34.3 to 61.8) 43.9 (35.9 to 51.9)* 40.0 (30.4 to 49.5)* 43.8 (30.0 to 57.5)
Eye examination 60.7 (57.9 to 63.6) 61.8 (51.8 to 71.8) 62.1 (51.6 to 72.6) 62.4 (56.9 to 68.0) 56.4 (48.9 to 63.8) 67.0 (56.4 to 77.6)
Foot examinations 30.3 (26.6 to 34.0) 24.9 (15.0 to 34.9) 22.4 (11.4 to 33.4) 25.6 (19.3 to 31.8) 24.8 (17.1 to 32.4) 24.6 (13.3 to 35.9)
Smoking habits 85.8 (83.0 to 88.7) 83.0 (74.3 to 91.6) 88.0 (79.9 to 96.0) 81.0 (75.2 to 86.7) 85.5 (79.5 to 91.5) 61.4 (47.8 to 75.1)*
Women, n 3797 81 142 368 140 46
HbA1c 91.3 (90.1 to 92.5) 86.2 (77.3 to 95.2) 89.2 (83.2 to 95.2) 91.9 (88.0 to 95.7) 93.7 (88.3 to 99.2) 79.7 (63.7 to 95.5)
Blood pressure 88.7 (87.4 to 90.1) 90.7 (83.6 to 97.9) 89.6 (84.1 to 95.1) 87.1 (82.6 to 91.7) 91.6 (86.2 to 97.1) 85.2 (72.9 to 97.5)
LDL-cholesterol 70.0 (66.3 to 73.8) 59.5 (45.9 to 73.2) 66.7 (56.86 to 76.6) 65.2 (57.6 to 72.8) 62.8 (51.6 to 74.1) 51.7 (32.5 to 70.9)
Creatinine/ e-GFR 87.0 (85.0 to 89.1) 82.7 (73.1 to 92.3) 84.7 (78.1 to 91.3) 86.9 (82.2 to 91.6) 85.0 (77.6 to 92.4) 77.5 (62.5 to 92.4)
Albuminuria 23.6 (17.9 to 29.3) 19.7 (9.2 to 30.2) 23.1 (13.9 to 32.3) 23.7 (16.1 to 31.3) 19.3 (10.6 to 28.0) 19.9 (6.0 to 33.9)
Body height 72.6 (68.1 to 77.1) 76.9 (65.8 to 87.7) 69.7 (60.0 to 79.4) 63.9 (55.9 to 71.9) 66.8 (55.7 to 77.9) 68.3 (49.5 to 87.0)
Body weight 53.1 (47.4 to 58.7) 56.3 (42.7 to 69.9) 43.4 (32.7 to 54.0) 49.0 (40.7 to 57.3) 51.7 (40.2 to 63.2) 41.6 (23.7 to 59.5)
Eye examination 63.1 (64.0 to 66.0) 53.5 (41.5 to 65.4) 73.0 (65.4 to 80.7) 65.0 (59.1 to 70.9) 66.1 (57.5 to 74.8) 69.2 (54.7 to 83.7)
Foot examination 29.3 (25.3 to 33.3) 25.1 (13.0 to 37.1) 25.7 (16.5 to 34.9) 24.7 (17.8 to 31.5) 24.5 (14.5 to 43.5) 25.8 (9.3 to 42.3)
Smoking habits 82.7 (79.4 to 85.9) 83.5 (73.7 to 93.4) 66.5 (65.3 to 76.7)* 55.3 (46.9 to 63.7)* 46.4 (34.9 to 57.8)* 42.5 (23.8 to 61.1)*
a MENA: Middle Easterners/North Africans. Multilevel binary regression models with random effects at general practice level were used to compare the ethnic
differences with Westerners as reference, adjusted for individual level characteristics (age, diabetes duration and education), general practitioner level
characteristics (gender, specialist status and years working as general practitioner in Norway) and county of residence in Norway. * No overlap in 95% CIs,
indicating significant difference between Westerners and the particular minority group
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(OR: 2.08 (1.19 to 3.62). Ethnic differences in achievement
of the treatment targets by gender are shown in Fig. 2.
Discussion
Our study is one of few from Europe that provides de-
tailed information about the quality of primary care for
T2DM by gender among six different ethnic groups, in-
cluding groups that have rarely been included in previ-
ous studies. The early onset of T2DM in minority
groups was also influenced by gender. GPs performance
of most of processes of care was comparable between
ethnic groups in both genders. Glucose-lowering agents
were more often prescribed in minority groups than in
Westerners regardless of gender. However, the propor-
tion who reached treatment targets was substantially
lower among men born in Eastern Europe, South Asia,
Middle East/North Africa and among women born in
Eastern Europe and South Asia compared with their
Western counterparts. Of particular concern was that
daily smoking was more prevalent among Eastern Euro-
peans, and among men born in South Asia and Middle
East/North Africa.
T2DM was diagnosed at a considerably younger age in
all five minority groups, especially in women, which
Fig. 2 Achievement of treatment targets in individuals with type 2 diabetes by ethnicity and gender. Multilevel binary regression models with
random effects at general practice level were used to estimate the difference in the ethnic groups compared to Westerners as reference, adjusted
for individual level characteristics (age, diabetes duration and education), general practitioner level characteristics (gender, specialist status and
years working as general practitioner in Norway) and county of residence in Norway. a HbA1c target ≤53mmol/mol (7.0%). bBlood pressure
combined target: ≤ 135/80mmHg with anti-hypertensives or ≤ 140/85mmHg without antihypertensive. c LDL-cholesterol combined target: for
individuals with coronary heart disease LDL-chol ≤1.8 mmol/L, without coronary heart disease ≤2.5 mmol/L with lipid lowering medication or≤
3.5 mmol/L for individuals without lipid lowering medication. d Missing observations. The number of observations included in univariate/
multivariate analyses for HbA1c target were 9059/8300, respectively. The corresponding number of observations included in regression analyses
for blood pressure target were 8897/8178 and for LDL-cholesterol target 6866/6313
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underscores the increased susceptibility of T2DM in mi-
nority women compared to Westerners [19]. This is
worrisome as many are in reproductive age when they
are diagnosed. Known or undiagnosed diabetes and ges-
tational diabetes, not least in young minority women,
may adversely affect pregnancy outcomes for the women
and offspring [20]. The ethnic differences in age at onset
of T2DM was in accordance with our previous study
and studies from other countries [2–4, 11, 21].
Performance of the processes of care is considered to
be a quality indicator in diabetes care, as this implies as-
sessment of the risk of developing complications, and
may increase the awareness of GPs to intensify treat-
ment when indicated. The state-funded health care ser-
vice to all citizens implies an equal access to core
elements in the public primary health care for T2DM.
This may have contributed to the finding of the GPs
equal performance for the measurements of HbA1c, BP,
LDL-cholesterol, creatinine and albuminuria regardless
of ethnicity and gender. The observed ethnic variations
by gender in measurements of body height, body weight
and the recording of smoking habits may be related to
individual factors such as comorbidity, specific needs/
wishes for consultations and how the GPs prioritize the
time spent in the consultations [22].
A new finding in our study is that Eastern Europeans of
both genders emerge as the minority group with the high-
est HbA1c level after adjustments for education and des-
pite a time of residence in Norway that is comparable to
most other minority groups. Importantly, we found smaller
differences in mean HbA1c between Westerners and South
Asians, Middle Easterners/North Africans in 2014 than in
our previous study from 2005 [2] and in most other reports
[15, 21] despite the fact that Norwegian GPs are not incen-
tivized to meet treatment targets as in UK and some other
countries. More options for intensive treatment in minority
groups may have contributed to our observations as more
glucose-lowering agents have become available.
Despite the new finding of poor glycaemic control in
Eastern Europeans, South Asians still have a higher HbA1c
level compared with Westerners, possibly explained by a
poorer β-cell function and less ability to compensate ad-
equately for higher glucose levels from insulin resistance
[23]. Poor adherence to prescribed blood glucose lowering
medication and recommended life style modifications
might partly explain why GPs do not manage to achieve
treatment targets for glycaemic control [24, 25]. Difficulties
in cross-cultural communication between minorities and
GPs may also contribute to ethnic differences in self-care
management and glycaemic control [26, 27].
Although South Asians and Middle Easterners/North
Africans reach BP targets more frequently than Westerners,
in agreement with our previous study and reports from
Scotland and Sweden [2, 4, 11], GPs should bear in mind
that South Asians have a higher risk for CVD at a given BP
level compared with Westerners [1].
We found small differences between Westerners and
ethnic minorities in mean LDL-cholesterol levels,
achievement of LDL-cholesterol targets and the propor-
tion receiving prescriptions for lipid-lowering agents, in
accordance with reports from Scotland [4]. Long resi-
dent time in Norway among minorities may have en-
hanced their language skills and contribute to diminish
the previously observed ethnic differences in HbA1c
level as well as BP and LDL-cholesterol level.
We have also identified ethnic and gender differences
in smoking habits which is consistent with the World
Health Organization’s report about tobacco use globally
[28]. Daily smoking among Eastern Europeans, men
born in South Asia and Middle East/North Africa repre-
sents an additional risk for cardiovascular complications.
Strengths and weaknesses
This study has several strengths as it is a large population-
based study conducted in general practice with high par-
ticipation rates for GPs that included all individuals with
diabetes on the GP lists. The study population is consid-
ered to be representative for the population with T2DM
in Norway [7]. Through linkage with data from the gov-
ernmental based national data source “Statistics Norway”,
we have data about ethnicity and could adjust for educa-
tion. We were also able to collect information about other
possible confounders as several GP factors. Not least, the
manual verification of diabetes diagnosis and the electron-
ically extracted data by experienced research nurses con-
tributes to the internal validity of this study.
Our study has some limitations as we used cross-
sectional EHR data. Some inconsistency between ele-
ments of care that is documented (i.e. smoking habits,
and weight) and what was actually measured may be
present. Although the low number in most minority
groups limits the power, particularly for analyses by gen-
der, we found it important also to report these results,
as little is known about some of these groups and gender
differences. Our results were not adjusted for individual
socio-economic status beyond education. We do not
have data about how the GPs approached lifestyle man-
agement. Further, we lack information about diabetes
self-care including lifestyle and compliance to lifestyle
modification and prescribed medication. HbA1c is a
measure of average glycaemia and is influenced by sev-
eral factors, i.e. hemoglobin levels and possible ethnic
differences in glycation independent of blood glucose
levels as previously shown in South Asians [23, 29].
Implications
For GPs, our findings highlight the importance of timely
diagnosis of T2DM among ethnic minorities. Intensive
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glucose lowering treatment and improved performance
of screening procedures for microvascular complications
and recording of smoking habits should be prioritized to
reduce the risk for future cardiovascular complications.
Smoking cessation advice should be frequently offered
to most groups of ethnic minority men. Qualitative stud-
ies exploring the influences of individuals cultural- and
socioeconomic factors on glycaemic control would be of
great value to enhance the understanding about differ-
ences between the ethnic groups. Future research pro-
viding knowledge about the needs of minorities with
T2DM in self-care and the GPs challenges in providing
optimal diabetes care for minorities in order to develop
culturally adapted patient education and tailored educa-
tion of GPs would be necessary. Further, public health
strategies for preventing early onset of T2DM are war-
ranted among ethnic minorities, especially for women.
Conclusion
We have identified earlier onset of T2DM in all minority
groups compared with Westerners, in particular in mi-
nority women. We found no gender difference in the
age at diagnosis in all minority groups, in contrast to
Westerners. The quality of diabetes care in terms of pro-
cesses of care, was, with few exceptions, equally well per-
formed in all ethnic groups irrespective of gender.
Worse achievement of treatment targets for HbA1c in
Eastern Europeans, South Asians and men from the
Middle East/North Africa and highly prevalent daily
smoking among men in several minority groups repre-
sents present major concerns.
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